For a complete transaction value of around $2.

The tender offer is definitely conditioned on the tender of most the outstanding shares of AMO’s common stock on a fully diluted basis. The $2.8 billion approximated value of the deal is based on AMO’s approximately 62 million fully diluted shares outstanding, plus estimated net debt at the right time of closing. The Boards of Directors of AMO and Abbott have approved the transaction. Abbott expects the transaction to become neutral to ongoing earnings per share in 2009 2009, and accretive from 2010, both before one-time transaction-related costs, which is offered at a later date. The transaction is subject to customary closing conditions, including antitrust clearances.You can view the entire Kaiser Daily Health Plan Report, search the archives, or join email delivery of in-depth coverage of health policy developments, debates and discussions. The Kaiser Daily Health Policy Report is released for, a free services of The Henry J. Kaiser Family Foundation. Copyright 2006 Advisory Board Firm and Kaiser Family Base. All rights reserved.

ATLIS 2010 shows gap in patient-physician dialogue that might negatively impact patients’ quality of life Results from the landmark Helps Treatment for Life International Survey , a multi-country survey of more than 2,000 people coping with HIV/Helps , revealed a significant gap in patient-physician dialogue about critical health-related conditions that may negatively impact patients’ general long-term health, standard of living, and treatment outcomes.